Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/27/11 → 7/27/14 |
Funding
- Merck Sharp & Dohme Corporation (Prot # 003-00)
Prot # 003-00: Randomized, Active-Controlled, Dose-Ranging Estimation Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-5172 When Administered Concomitantly with Peginterferon alfa-2b and Ribavirin in Treatment-Naive Pat
- Flamm, Steven L (PD/PI)
- Ganger, Daniel R (Co-Investigator)
Project: Research project